1. Zhang, Wentao, Qu, Haizeng, Ma, Xiaoqing, Zhou, Fengge, Yang, Zhe. 2023. Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma. In Frontiers in immunology, 14, 1179742. doi:10.3389/fimmu.2023.1179742. https://pubmed.ncbi.nlm.nih.gov/37622116/
2. Dornan, David, Bennett, Fiona, Chen, Yvonne, Ebens, Allen, Polson, Andrew G. 2009. Therapeutic potential of an anti-CD79b antibody-drug conjugate, anti-CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma. In Blood, 114, 2721-9. doi:10.1182/blood-2009-02-205500. https://pubmed.ncbi.nlm.nih.gov/19633198/
3. Pu, Dan, Liu, Dan, Li, Can, Yang, Yang, Wang, Xuelian. 2022. A novel ten-gene prognostic signature for cervical cancer based on CD79B-related immunomodulators. In Frontiers in genetics, 13, 933798. doi:10.3389/fgene.2022.933798. https://pubmed.ncbi.nlm.nih.gov/36406115/
4. Wilson, Wyndham H, Wright, George W, Huang, Da Wei, Shreeve, Martin, Staudt, Louis M. 2021. Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL. In Cancer cell, 39, 1643-1653.e3. doi:10.1016/j.ccell.2021.10.006. https://pubmed.ncbi.nlm.nih.gov/34739844/
5. Takeuchi, Toshifumi, Yamaguchi, Motoko, Kobayashi, Kyoko, Tanaka, Kyosuke, Katayama, Naoyuki. 2016. MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma. In Cancer, 123, 1166-1173. doi:10.1002/cncr.30404. https://pubmed.ncbi.nlm.nih.gov/27915469/
6. Shen, Rong, Fu, Di, Dong, Lei, Xu, Peng-Peng, Zhao, Wei-Li. 2023. Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma. In Signal transduction and targeted therapy, 8, 145. doi:10.1038/s41392-023-01358-y. https://pubmed.ncbi.nlm.nih.gov/37032379/
7. Ramis-Zaldivar, Joan Enric, Gonzalez-Farré, Blanca, Balagué, Olga, Campo, Elías, Salaverria, Itziar. . Distinct molecular profile of IRF4-rearranged large B-cell lymphoma. In Blood, 135, 274-286. doi:10.1182/blood.2019002699. https://pubmed.ncbi.nlm.nih.gov/31738823/
8. Sun, Yanzi, Wang, Yishu, Liu, Chunyan, Zhang, Can, Chen, Yijun. 2024. Targeted degradation of oncogenic BCR-ABL by silencing the gene of NEDD8 E3 ligase RAPSYN. In Journal of nanobiotechnology, 22, 247. doi:10.1186/s12951-024-02505-5. https://pubmed.ncbi.nlm.nih.gov/38741123/
智鼠故事 
